Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: A pilot study

Lupus

Volumn 7, Issue 1, 1998, Pages 29-36

  Dostal C ^a,c   Tesar V ^b   Rychlik I ^b   Zabka J ^b   Vencovsky J ^a   Bartunkova J ^b   Stejskalova A ^b   Tegzova, D ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Na Slupi 4 Praha 2   (Czech Republic)

Author keywords

Cyclosporine A; Lupus nephropathy; Treatment

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOUBLE STRANDED DNA; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY TITER; ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; GINGIVA HYPERPLASIA; HIRSUTISM; HUMAN; HYPERTENSION; KIDNEY BIOPSY; LONG TERM CARE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOPSY; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PILOT PROJECTS;

EID: 0031983352     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678919714     Document Type: Article

References (22)

1. Boumpas DT et al. SLE: emerging concepts. Part 1. Ann Internal Med 1995; 122: 940-950, Part 2. 123: 42-53.
2. Boumpas DT et al. SLE: emerging concepts. Part 1. Ann Internal Med 1995; 122: 940-950, Part 2. 123: 42-53.
3. Steinberg AD, Gourley M. Cyclophosphamide in lupus nephritis; J Rheumatol 1995; 22: 1812-1815.
4. Klippel JH. Curing lupus views from the foothills. Ann Rheum Dis Leaders 1994; 53: 785-786.
5. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1734.
6. Cruse JM, Lewis RE Jr. Cyclosporin therapy of autoimmune disease. In Therapy of Autoimmune Disease. JM Cruse, RE Lewis Jr, Karger, Basel: 1989.
7. Radhakrishnan J, Valeri K, Kunis C, Appel GB. Use of cyclosporin in lupus nephritis.(ed.). Tejani A Karger: 1995, Basel. In Cyclosporin in the Therapy of Renal Disease 59-72.
8. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-h 1277.
9. Bombardieri C et al. and the Committee on Prognostic Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients.; Arthritis Rheum 1992; 35: 630-640.
10. Churg J, Bernstein J, Glassock RJ. Renal Disease. Classification and Atlas of Glomerular Diseases; (2nd edn). New York, Tokyo, Igaku-Shoin: 1995.
11. Isenberg DA, Snaith ML, Morrow NJW. Effects of cyclosporin in severe systemic lupus erythematosus. J Pediatr 1987; 111: 1063-1068.
12. Feutren G et al. Effects of cyclosporin in severe systemic lupus erythematosus. J Pediatr 1987; 111: 1063-1068.
13. Miescher PA, Miescher A. Combined cyclosporin-steroid treatment of systemic lupus erythematosus. Cyclosporin in Autoimmune Disease (ed.) R. Schneider Springer Berlin, 1985.
14. Favre H et al. Cyclosporine in the treatment of lupus nephritis. Am J Nephrol 1989; 9 (Suppl.): 57-60.
15. Collaboration study group of Sandimmun Nephrotic syndrome safety and tolerability of Cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Clin Nephrol 1991; 35 (Suppl. 1): 48-60
16. Cattran DC. Current status of cyclosporin A in the treatment of membranous IgA and membranoproliferative glomerulonephritis. Clin Nephrol 1991; 35 (Suppl. 1): 43-47.
17. Guasch A et al. Short-term responsiveness of membranous glomerulopathy to Cyclosporine. Ann J Kidney Dis 1992; 20: 472-481.
18. Radhakrishnan J, Kunis CL, D'Agati V, Appel GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994; 42: 147-154.
19. Tokuda M et al. Effect of low-dose cyclosporine A on SLE disease activity. Arthritis Rheum 1994; 37: 551-558.
20. Bloemena E et al. Prednisolone and cyclosporine A exert differential inhibitory effects on T cell proliferation in vitro. Clin Immunol Immunopathol 1988; 48: 380-391.
21. Fracnkel L et al. Response to the treatment as a predictor of long term outcome in patients with lupus nephritis. J Rheumatol 1994; 21: 2052-2057.
22. Caccavo D et al. Long-term treatment of systemic lupus erythematosus with cyclosporine A. Arthritis Rheum 1997; 40: 27-35.